
|Articles|December 19, 2013
Generic version of Vfend now available
Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., has introduced voriconazole for oral suspension, an authorized generic version of Vfend.
Advertisement
Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., has introduced voriconazole for oral suspension, an authorized generic version of Vfend.
The antifungal agent will be offered in a dosage strength of 40 mg/mL. Voriconazole (Vfend, Pfizer) was approved for use in the treatment of invasive aspergillosis and the treatment of serious fungal infections caused by Scedosporium apiospermum and Fusarium spp in patients intolerant of, or refractory to, other therapy.
Full prescribing information is available
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Q&A: Pharmacists Can Address ADA Standards Across All Settings
5





























































